National Accreditation Board Suspends All DNA Testing at D.C. Crime Lab
By Keith L. Alexander,
Washington Post
| 04. 27. 2015
Untitled Document
One of the national organizations that govern DNA laboratories has ordered the District’s new crime lab to immediately suspend all DNA casework after concluding that the lab’s procedures are “insufficient and inadequate.”
D.C. Mayor Muriel E. Bowser ordered the audit by the ANSI-ASQ National Accreditation Board last month after the U.S. attorney’s office said it had discovered numerous errors in some of the lab’s DNA analyses. The audit, which was published Friday, criticized the lab’s practices and said they were not in compliance with FBI standards. It ordered “at a minimum” the revalidation of test procedures, new interpretation guidelines for DNA mixture cases, additional training and competency testing of staff.
The DNA analysts at the District’s Department of Forensic Sciences, according to the audit, “were not competent and were using inadequate procedures.” The authors of the review said the lab must begin to address the concerns within 30 days.
Legal experts say the audit could trigger a further investigation of hundreds of District criminal cases — including murder, sexual assault and gun possession cases — that have involved...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...